Does avidity on FDG PET exclude the need for a percutaneous biopsy in the diagnosis of de-differentiation in retroperitoneal liposarcoma? The emerging role of the metabolic biopsy?

Nobrega R.P, Bradley K.M., Gibbons C.R.M., Whitwell D., Hassan B., Pratap S.,Sullivan M.E.

European Urology Open Science（2020）

引用 0|浏览1